Abstract-The matricellular protein thrombospondin (TSP) 1 is induced after tissue injury and may regulate reparative responses by activating transforming growth factor-␤, by suppressing angiogenesis and by modulating inflammation and matrix metabolism. We hypothesized that endogenous TSP-1 may be involved in the pathogenesis of cardiac remodeling in the pressure-overloaded heart. Myocardial TSP-1 expression was increased in a mouse model of pressure overload because of transverse aortic constriction. TSP-1 Ϫ/Ϫ mice exhibited increased early hypertrophy and enhanced late dilation in response to pressure overload. Pressure-overloaded TSP-1 null mice had intense degenerative cardiomyocyte changes, exhibiting more extensive sarcomeric loss and sarcolemmal disruption when compared with wild-type hearts. Accentuated hypertrophy and cardiomyocyte injury in TSP-1 Ϫ/Ϫ hearts was accompanied by increased myofibroblast density. However, despite a 2-fold higher infiltration of the cardiac interstitium with myofibroblasts, pressureoverloaded TSP-1 null hearts did not exhibit significantly increased collagen content when compared with wild-type hearts. The disproportionately low collagen content in TSP-1 null hearts was attributed to infiltration with abundant, but functionally defective, fibroblasts that exhibited impaired myofibroblast differentiation and reduced collagen expression in comparison with wild-type fibroblasts. Impaired myofibroblast activation in TSP-1 null hearts was associated with reduced Smad2 phosphorylation reflecting defective transforming growth factor-␤ signaling. Moreover, TSP-1 null hearts had increased myocardial matrix metalloproteinase 3 expression and enhanced matrix metalloproteinase 9 activation after pressure overload. TSP-1 upregulation in the pressure-overloaded heart critically regulates fibroblast phenotype and matrix remodeling by activating transforming growth factor-␤ signaling and by promoting matrix preservation, thus preventing chamber dilation. (Hypertension. 2011;58:902-911.) • Online Data Supplement Key Words: fibrosis Ⅲ matricellular proteins Ⅲ cardiac remodeling Ⅲ thrombospondin 1 Ⅲ myofibroblast Ⅲ transforming growth factor-␤1 Ⅲ collagen P ressure overload induces cardiac remodeling through effects on both cardiomyocytes and cardiac interstitial cells. Hypertrophy and apoptosis of cardiac myocytes play an important role in the development of heart failure in the pressureoverloaded heart. 1,2 On the other hand, fibroblast activation is a hallmark of the cardiomyopathic process after pressure overload, and results in accentuated deposition of collagen in the cardiac interstitium, increasing myocardial stiffness and inducing diastolic dysfunction. 3 Beyond its effects on the cellular elements of the myocardium, pressure overload also markedly alters the composition of the extracellular matrix network. 4 It is becoming increasingly appreciated that extracellular matrix proteins not only determine the mechanical properties of the ventricle but also play an important role in modulating cellular responses in the remodeling myocardium. 5 Cardiac injury induces expression of the matricellular proteins, 6 a family of extracellular matrix proteins that, unlike collagen or elastin, do not serve a structural role but modulate cell:cell and cell:matrix interactions. 7 Several members of the matricellular family (including tenascin-C, osteopontin, periostin, secreted protein, acidic cysteine-rich, and the thrombospondins) have been implicated in cardiac remodeling, either by maintaining the integrity of the extracellular matrix 8 or by inducing phenotypic alterations on cardiomyocytes and fibroblasts. 9, 10 
P ressure overload induces cardiac remodeling through effects on both cardiomyocytes and cardiac interstitial cells. Hypertrophy and apoptosis of cardiac myocytes play an important role in the development of heart failure in the pressureoverloaded heart. 1,2 On the other hand, fibroblast activation is a hallmark of the cardiomyopathic process after pressure overload, and results in accentuated deposition of collagen in the cardiac interstitium, increasing myocardial stiffness and inducing diastolic dysfunction. 3 Beyond its effects on the cellular elements of the myocardium, pressure overload also markedly alters the composition of the extracellular matrix network. 4 It is becoming increasingly appreciated that extracellular matrix proteins not only determine the mechanical properties of the ventricle but also play an important role in modulating cellular responses in the remodeling myocardium. 5 Cardiac injury induces expression of the matricellular proteins, 6 a family of extracellular matrix proteins that, unlike collagen or elastin, do not serve a structural role but modulate cell:cell and cell:matrix interactions. 7 Several members of the matricellular family (including tenascin-C, osteopontin, periostin, secreted protein, acidic cysteine-rich, and the thrombospondins) have been implicated in cardiac remodeling, either by maintaining the integrity of the extracellular matrix 8 or by inducing phenotypic alterations on cardiomyocytes and fibroblasts. 9, 10 Thrombospondin (TSP) 1 is the archetypal matricellular protein, a 450-kD homotrimeric protein with multiple functional domains. 11 TSP-1 is upregulated in injured tissues and is capable of regulating wound healing and tissue remodeling by modulating a variety of cellular functions essential to the reparative process. 12 First, TSP-1 functions as an essential activator of transforming growth factor (TGF)-␤ signaling 13 through an association with the latent complex that results in a conformational rearrangement in the latency-associated peptide (LAP) and renders the TGF-␤ dimer biologically active. 14, 15 Second, TSP-1 exerts potent angiostatic actions through direct effects on endothelial cells that result in inhibition of proliferation and increased apoptosis. 16, 17 Third, TSP-1 directly inhibits inflammation through CD47-mediated interactions. 18 Fourth, TSP-1 modulates matrix metabolism by inhibiting matrix metalloproteinase (MMP) activation. We, and others, have reported important effects of TSP-1 in cardiac injury and repair. In healing myocardial infarction, TSP-1 is selectively deposited in the border zone and may serve as a protective "barrier" that protects the noninfarcted myocardium from extension of the inflammatory infiltrate by locally activating anti-inflammatory signals. 19, 20 Moreover, in a rat model of diabetic cardiomyopathy exacerbated by abdominal aortic coarctation, TSP-1 expression was upregulated, and administration of a peptide antagonist of TSP-1-dependent TGF-␤ activation prevented the development of cardiac fibrosis. 21 Although these findings suggest that TSP-1 may modulate myocardial inflammation and repair, its role in cardiac remodeling because of pressure overload has not been investigated.
Our study examines for the first time the role of TSP-1 in the development of the fibrotic cardiomyopathy associated with pressure overload. We report that TSP-1 is markedly upregulated in the myocardial interstitial space after experimental transverse aortic constriction (TAC). TSP-1 gene disruption resulted in adverse cardiac remodeling of the pressure-overloaded heart, associated with infiltration of the myocardium with abundant, but dysfunctional, fibroblasts that exhibited defective myofibroblast transdifferentiation and decreased matrix-synthetic capacity. Accumulation of functionally impaired fibroblasts in the remodeling myocardium was associated with defective activation of TGF-␤/Smad3 signaling and enhanced MMP activity. Our findings suggest that TSP-1 deposition in the extracellular matrix of the pressure-overloaded heart activates TGF-␤-mediated signaling in reparative cardiac fibroblasts and preserves the extracellular matrix, affording protection from adverse remodeling.
Methods
A detailed description of the Methods is provided in the online Data Supplement (please see http://hyper.ahajournals.org). Animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Baylor College of Medicine and Albert Einstein College of Medicine institutional review boards. Male and female, wild-type (WT) and TSP-1 null 13 C57/BL6 mice from our colony were genotyped using established protocols and underwent TAC as described previously. 22 Functional assessment of the pressure-overloaded mouse heart was performed using echocardiography. At the end of the experiment, the heart was excised, fixed in zinc formalin, and embedded in paraffin for histological studies or frozen for RNA or protein isolation. Animals used for histology underwent 3, 7, and 28 days of banding (nϭ8 per group). Additional groups of mice were used for RNA and protein extraction after 3 (nϭ7) or 7 days (nϭ7) of banding, for isolation and flow cytometric analysis of cardiac fibroblasts (WT: nϭ10; TSP-1 Ϫ/Ϫ : nϭ6), and for assessment of collagen content using a biochemical hydroxyproline assay (WT: nϭ9; knockout: nϭ12). As a control, a "sham" operation without aortic constriction was performed on age-matched mice (histology: nϭ6; RNA: nϭ6; protein: nϭ6). The effects of TSP-1 loss on the inflammatory and fibrotic responses were studied using immunohistochemistry, quantitative histology, quantitative PCR, ribonuclease protection assays, and Western blotting. Effects on apoptosis of cardiomyocytes and interstitial cells were investigated using TUNEL staining combined with wheat germ agglutinin lectin fluorescence to outline the surface of cardiomyocytes. The consequences of TSP-1 deficiency on TGF-␤ signaling were studied through assessment of Smad2 phosphorylation using Western blotting. Effects on matrix metabolism were assessed using zymography, whereas collagen content was measured with a hydroxyproline biochemical assay. The role of TSP-1 in modulating fibroblast phenotype and function in the pressure-overloaded myocardium was studied using isolated cardiac fibroblasts and flow cytometry on cells harvested from the myocardium. 23 
Results

TSP-1 Is Upregulated in the Pressure-Overloaded Myocardium
Using quantitative PCR we demonstrated that TSP-1 mRNA expression was markedly induced in the pressure-overloaded heart after 3 to 7 days of TAC ( Figure 1A) . Immunohistochemical staining demonstrated that TSP-1 protein was primarily localized in the cardiac interstitial and perivascular space after 7 to 28 days of TAC ( Figure 1B and 1C) . TSP-1 immunoreactivity was absent in control mouse myocardium.
TSP-1 Null Mice Exhibit Increased Early Mortality After TAC
TSP-1 null and WT mice exhibited comparable mortality after TAC (survival after 28 days of TSP-1 Ϫ/Ϫ 57.9% versus WT 55.3%; P value not significant; Figure 1D ). However, TSP-1 null mice had significantly increased early mortality over the first 3 days after TAC (percentage of survival after 3 days of TSP-1 Ϫ/Ϫ 65.7% versus WT 80.3%; Pϭ0.05).
TSP-1 Null Mice Have Increased Hypertrophy and Dilation After Pressure Overload
In the absence of injury, WT and TSP-1 null mice had comparable cardiac dimensions, function, and left ventricular (LV) mass (Table 1 ). After 7 days of TAC, WT mouse hearts exhibited a marked increase in LV mass, associated with reduced LV end-diastolic diameter, indicating the development of concentric LV hypertrophy. At the same time point, TSP-1 null mice had accentuated hypertrophic remodeling exhibiting significantly higher LV mass and a trend for a higher LV end-diastolic diameter in comparison with WT animals (Table 1 ). After 28 days of TAC, LV mass was comparable between TSP-1 Ϫ/Ϫ and WT mice; however, TSP-1 null animals exhibited significantly higher LV end-diastolic diameter when compared with WT mice (PϽ0.05; Table 1 ). Thus, TSP-1 deficiency was associated with increased early hypertrophy and enhanced late dila-tion in response to pressure overload. LV fractional shortening was comparable between WT and TSP-1 Ϫ/Ϫ mice at all of the time points examined, suggesting that the absence of TSP-1 did not affect the development of systolic dysfunction in the pressure-overloaded heart.
Effects of TSP-1 Absence on Cardiomyocyte Alterations and Apoptosis in the Pressure-Overloaded Heart
To examine the basis for enhanced cardiac remodeling after TAC in the absence of TSP-1, we compared the pathological alterations in WT and TSP-1 null pressureoverloaded hearts. In both WT and TSP-1 null mice, TAC resulted in widening of the cardiac interstitium and focal cardiomyocyte degeneration. TSP-1 null animals had more intense cardiomyocyte changes after 3 to 7 days of TAC in comparison with WT animals, exhibiting more extensive sarcomeric loss and sarcolemmal disruption (Figure 2A through 2D). Combined TUNEL/wheat germ agglutinin lectin staining ( Figure 2E through 2H) was used to identify apoptotic cardiomyocytes in the pressure-overloaded heart.
In both WT and TSP-1 null mice, the majority of apoptotic cells in the pressure-overloaded myocardium were noncardiomyocytes; apoptotic cardiomyocytes were rare. In WT hearts, the density of apoptotic cardiomyocytes peaked after 3 days of TAC; in contrast, TSP-1 null animals had a delayed peak in the number of apoptotic cells after 7 days of TAC ( Figure 2I ). The number of apoptotic interstitial cells was comparable between WT and TSP-1 null hearts at all of the time points examined ( Figure 2J ). TSP-1 null mice and WT animals showed comparable mortality after 28 days of TAC (P value not significant) but had lower survival rates during the first 3 days of pressure overload (Pϭ0.05).
Despite a Marked Increase in Myofibroblast
Table 1. Echocardiographic Analysis of Systolic Function and Chamber Dimensions
Functional Parameter 
TSP-1 Absence Does Not Affect the Inflammatory Response in the Pressure-Overloaded Heart
Because TSP-1 is an important modulator of the inflammatory response, we examined whether increased cardiac remodeling in pressure-overloaded TSP-1 null mice is associated with increased expression of inflammatory mediators. TSP-1 null and WT animals showed no significant differences in the intensity and time course of the myocardial inflammatory response after TAC. RPA (RNAse protection assay) analysis demonstrated that expression of the proinflammatory cytokines tumor necrosis factor-␣, interleukin 1␤, and interleukin 6 was comparable between TSP-1 Ϫ/Ϫ and WT hearts after 3 to 7 days of TAC (Table 2) . Mac-2 immunohistochemistry showed that macrophage density was comparable between WT and TSP-1 null mice after 3 to 28 days of TAC ( Figure 4A through 4C ). In addition, expression of the CC chemokine monocyte chemoattractant protein (MCP) 1, a critical regulator of mononuclear cell recruitment, was comparable between groups ( Figure 4D ).
TSP-1 Absence Does Not Affect the Angiogenic Response in the Pressure-Overloaded Myocardium
Because TSP-1 is a potent regulator of angiogenesis, we examined whether the altered response of TSP-1 Ϫ/Ϫ hearts to pressure overload may be attributed to changes in microvascular density. Cardiac microvessels were identified using staining with the endothelial marker CD31 ( Figure 4E and 4F). TSP-1 null and WT animals showed no significant difference in microvascular density after 7 to 28 days of pressure overload ( Figure 4G and 4H).
Impaired Activation of TGF-␤/Smad2/3 Signaling in the Pressure-Overloaded Heart
The TGF-␤/Smad2/3 pathway plays an important role in the pathogenesis of cardiac fibrosis. Because TSP-1 is an essential activator of TGF-␤, we examined the effects of TSP-1 gene disruption on TGF-␤ signaling in the pressureoverloaded heart. WT and TSP-1 null hearts exhibited comparable levels of TGF-␤1 mRNA and protein expression after 3 to 7 days of TAC ( Figure 5A and 5B). Despite showing comparable TGF-␤1 levels, TSP-1 Ϫ/Ϫ animals had significantly reduced expression of p-Smad2 in the pressureoverloaded heart after 7 days of TAC, suggesting an important role for TSP-1 in activation of profibrotic TGF-␤ signaling ( Figure 5C and 5D ). In the absence of pressure overload, sham WT and TSP-1 null hearts had comparable myocardial p-Smad2 expression (P value not significant).^* D) exhibited more intense alterations in cardiomyocyte morphology (including sarcomeric loss, hypereosinophilia, and contraction band necrosis; arrows) than WT hearts. E through H, Apoptosis of cardiomyocytes and noncardiomyocytes was quantitatively assessed using TUNEL staining (green, arrows), combined with wheat germ agglutinin lectin histochemistry that outlines the surface of cardiomyocytes (red). The density of apoptotic cardiomyocytes (G, arrow) and interstitial cells (H, arrows) was quantitatively assessed in WT (E) and TSP-1 Ϫ/Ϫ (F) hearts after 3 to 28 days of TAC. 4Ј,6-Diamidino-2-phenylindole (DAPI) staining (blue) was used to label all of the nuclei in the murine myocardium. I and J, The majority of apoptotic cells were noncardiomyocytes; TUNELϩ cardiomyocytes were rare. TSP-1 Ϫ/Ϫ mice had lower early cardiomyocyte apoptosis after 3 days of TAC but exhibited a significantly higher apoptotic cardiomyocyte density after 7 days (*PϽ0.05 vs WT; I). The number of apoptotic noncardiomyocytes was comparable between groups (J;ˆPϽ0.05,ˆˆPϽ0.01 vs sham).
TSP-1 Null Mice Show Increased MMP-3 Expression and Enhanced MMP-9 Activity in the Pressure-Overloaded Myocardium
MMPs play an important role in cardiac remodeling, and TSP-1 regulates MMP expression and activity both indirectly by activating TGF-␤ and directly through inhibition of MMP-9 activity. Accordingly, we examined whether TSP-1 absence affected MMP expression in the pressureoverloaded heart. After 7 days of TAC, TSP-1 Ϫ/Ϫ animals exhibited markedly higher expression of MMP-3 protein in the pressure-overloaded myocardium in comparison with WT animals ( Figure 6B ). In contrast, MMP-2, MMP-9, and tissue inhibitor of metalloproteinase 1 protein levels were comparable among groups. In addition, zymographic assessment of MMP activity demonstrated that active MMP-9 levels were significantly higher in TSP-1 null hearts ( Figure 6F ). Active MMP-2 levels were comparable among groups ( Figure 6E ).
TSP-1 Null Fibroblasts Harvested From the Pressure-Overloaded Heart Exhibit Impaired Myofibroblast Transdifferentiation and Reduced Collagen Synthesis
In the absence of TSP-1, cardiomyocyte injury in the pressure-overloaded heart is followed by replacement with abundant fibroblasts that produce disproportionately low amounts of collagen. We postulated that these findings may reflect functional impairment of TSP-1 null cardiac 
vs wild-type [WT]). Representative images showing ␣-SMA staining to identify myofibroblasts in WT (B)
and TSP-1 null (C) hearts after 7 days of pressure overload are shown. D through F, Cardiac pressure overload was associated with increased total and insoluble collagen content (measured with a hydroxyproline biochemical assay) and a higher ratio of insoluble:total collagen (ˆˆPϽ0.01 vs sham). Despite a markedly increased myofibroblast density, collagen content was not significantly higher in TSP-1 null hearts after 7 days of pressure overload (D). The amount of insoluble collagen (E) and the ratio of insoluble:total collagen (F) were comparable between TSP-1 Ϫ/Ϫ and WT animals. Sirius red staining showed that, whereas pressure-overloaded WT hearts had interstitial deposition of dense collagen (G, arrows), TSP-1 Ϫ/Ϫ animals had more extensive cardiomyocyte loss, associated with replacement by a matrix network composed of loose collagen (H, arrows).
Table 2. Cytokine mRNA Expression in the Pressure-Overloaded Heart
Ratio to L32 fibroblasts. To test this hypothesis we assessed type I collagen and ␣-smooth muscle actin (SMA) expression in myofibroblasts harvested from pressure-overloaded hearts after 7 days of TAC using 2 distinct methods. First, early passage myofibroblasts cultured from pressure-overloaded hearts underwent dual immunofluorescence for ␣-SMA and type I collagen. TSP-1 null myofibroblasts were smaller, exhibited a poorly developed network of ␣-SMA No statistically significant difference was observed in subendocardial (G, endo) and subepicardial (H, epi) microvascular density between WT and knockout hearts after 7 to 28 days of TAC (P value not significant). mice have suggested that several members of the matricellular family play an important role in the pathogenesis of cardiac remodeling associated with pressure overload by modulating responses that may involve cardiomyocytes and fibroblasts. Osteopontin induction in the pressureoverloaded myocardium mediates cardiomyocyte hypertrophy through integrin-associated interactions without affecting development of fibrosis. 24 Secreted protein acidic and rich in cysteine signaling is essential for postsynthetic collagen processing and cross-linking but does not affect cardiac hypertrophy; in its absence collagen deposition is reduced and myocardial diastolic stiffness is attenuated. 25 Periostin contributes to the development of cardiac hypertrophy and fibrosis and activates fibroblast adhesion and gene expression. 9 Members of the TSP family have been suggested to play a role in cardiac remodeling. TSP-2 expression appears to be essential for preservation of matrix integrity under conditions of stress; TSP-2 null animals exhibited a high incidence of cardiac rupture in a model of angiotensin II-mediated hypertrophy. 8 TSP-1 is also upregulated in the pressure-overloaded myocardium 8, 26 ; however, its role in the pathogenesis of cardiac remodeling remains unknown. Our study demonstrates for the first time that TSP-1 is induced in the pressure-overloaded myocardium and may serve as a protective signal that prevents development of cardiac remodeling through effects on fibroblast function and matrix metabolism. TSP-1 absence was associated with increased early hypertrophy and accentuated cardiac injury. In response to pressure overload, TSP-1 null hearts were infiltrated with abundant, but functionally impaired fibroblasts that exhibited defective myofibroblast transdifferentiation and reduced collagen synthesis. Alterations in 2 distinct pathways appear to be responsible for defective fibroblast activation and increased matrix remodeling in the pressure-overloaded TSP-1 Ϫ/Ϫ heart. First, TSP-1 absence was associated with attenuated TGF-␤/ Smad2 signaling, leading to an impairment in myofibroblast transdifferentiation and to reduced fibroblast-derived matrix synthesis. Second, TSP-1 was involved in regulation of matrix metabolism; TSP-1 loss resulted in enhanced MMP-9 activity and accentuated MMP-3 expression in the pressure-overloaded heart.
In the cardiac interstitium, extracellular matrix proteins not only form a structural framework that provides me- ; in contrast MMP-2, MMP-9, and tissue inhibitor of metalloproteinase (TIMP) 1 levels were comparable between groups (ˆPϽ0.05 vs sham). E, F, Zymography showed significantly increased MMP-2 and MMP-9 activity in the pressure-overloaded myocardium after 7 days of TAC (ˆPϽ0.05 vs sham). Active MMP-9 levels (aMMP-9) were significantly higher in TSP-1 hearts (C; *PϽ0.05 vs WT), whereas MMP-2 activity (aMMP-2) was comparable between WT and Ϫ/Ϫ hearts (B). G, A representative image of a zymogram comparing MMP activity in the pressure-overloaded myocardium between WT (ϩ/ϩ) and TSP-1 Ϫ/Ϫ mice after 7 days of TAC. Bands corresponding with active MMP-2 and active MMP-9 are identified.
chanical support but also transduce signals that regulate cell survival, phenotype, and function. TSP-1 limits adverse remodeling of the pressure-overloaded heart through modulatory effects on fibroblast function. Progressive cardiomyocyte loss triggers inflammatory and profibrotic pathways leading to infiltration of the pressure-overloaded myocardium with activated myofibroblasts. 22 Although TSP-1 is known to exert direct anti-inflammatory actions through CD47, 18 TSP-1 null and WT mice exhibited comparable levels of inflammatory signals in the pressureoverloaded myocardium (Table 2) . However, TSP-1 absence significantly affected maturation and activation of myofibroblasts in the pressure-overloaded heart. Because of increased cardiomyocyte injury, TSP-1 null hearts exhibited markedly accentuated myofibroblast infiltration and more extensive areas of reparative fibrosis. However, despite the increased number of fibroblasts, TSP-1 null hearts showed no significant increase in collagen content after pressure overload (Figure 3) , reflecting the functional impairment observed in TSP-1 null fibroblasts. Flow cytometry and immunofluorescence on cells harvested from the remodeling pressure-overloaded myocardium demonstrated that, in the absence of TSP-1, cardiac fibroblasts exhibited defective myofibroblast transdifferentiation and significantly reduced collagen synthesis ( Figure  7 ). These defects were associated with a significant decrease in Smad2 phosphorylation, suggesting that impaired fibroblast activation in the absence of TSP-1 may be because of defective TGF-␤ activation ( Figure 5 ). TSP-1 is critically involved in TGF-␤ activation by binding to the LAP, inducing a conformational change in the latent complex that renders the TGF-␤ dimer biologically active. In addition, the LAP:TSP-1 interaction may occupy LAP molecules, preventing the generation of new inactive LAP:TGF-␤ small latent complexes, because TSPassociated LAP does not confer latency on active TGF-␤. 15 Why does impaired myofibroblast activation in TSP-1 null pressure-overloaded hearts contribute to adverse remodeling? The functional consequences of TSP-1 loss are probably attributed to the combination of defective myofibroblast function and accentuated matrix remodeling. In the absence of TSP-1, impaired TGF-␤ signaling in cardiac fibroblasts results in decreased collagen deposition, leading to formation of a matrix that provides inadequate mechanical support to the ventricle. In addition, accentuated MMP-3 expression and MMP-9 activity in TSP-1 Ϫ/Ϫ pressure-overloaded hearts ( Figure 6 ) may also contribute to adverse remodeling by promoting matrix degradation. Because MMP-3 is the most efficient MMP-9 activator identified to date, 27 the increased MMP-9 activity observed in TSP-1 null pressure-overloaded hearts may be attributed to accentuated MMP-3 expression. Inhibitory effects of TSP-1 on MMP-9 activity have been suggested previously to play an important role in suppression of tumor growth. 28 It should be noted that, despite the increased matrix degradation and enhanced cardiomyocyte injury observed in TSP-1 null hearts after pressure overload, cardiac systolic function was preserved. This finding suggests that TSP-1 absence does not affect cardiomyocyte contractility but may also reflect the compensatory effects of the increased LV mass in TSP-1 Ϫ/Ϫ hearts.
Perspectives
The effects of TSP-1 in the remodeling heart are attributed to a combination of protective actions involving cardiac fibroblasts and the extracellular matrix. Pressure overload results in early MMP activation and matrix degradation; stimulation of a matrix-preserving fibroblast phenotype provides mechanical support to the myocardium preventing chamber dilation and adverse remodeling. TSP-1 induction in the cardiac interstitium may serve as a protective mechanism against cardiac remodeling that regulates the reparative properties of cardiac fibroblasts activating TGF-␤ signaling and inhibiting MMP activity, thus promoting matrix preservation. 
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